Methylselenocysteine preventing castration‐resistant progression of prostate cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0045|75|9|1001-1008

ISSN： 0270-4137

Source： THE PROSTATE, Vol.75, Iss.9, 2015-06, pp. : 1001-1008

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Immunotherapy in Castration‐Resistant Prostate Cancer (CRPC)

By  

BJU INTERNATIONAL, Vol. 113, Iss. 3, 2014-03 ,pp. : 367-375

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Role of Palliative Surgery in Castration-Resistant Prostate Cancer

By  

Oncology Research and Treatment, Vol. 38, Iss. 12, 2015-0 ,pp. : 670-677

Karger

Access to resources Recommend Favorite

Variant allele of HSD3B1 increases progression to castration‐resistant prostate cancer

By  

THE PROSTATE, Vol. 75, Iss. 7, 2015-05 ,pp. : 777-782

John Wiley & Sons Inc

Access to resources Recommend Favorite

Metastasis initiating cells in primary prostate cancer tissues from transurethral resection of the prostate (TURP) predicts castration‐resistant progression and survival of prostate cancer patients

By  

THE PROSTATE, Vol. 75, Iss. 12, 2015-07 ,pp. : 1312-1321

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is prostate cancer changing?: Evolving patterns of metastatic castration‐resistant prostate cancer

By  

CANCER, Vol. 120, Iss. 6, 2014-03 ,pp. : 833-839

John Wiley & Sons Inc

Access to resources Recommend Favorite